Press Releases

Press Releases

WATERTOWN, Mass.--( BUSINESS WIRE )--C4 Therapeutics (C4T), a biopharmaceutical company pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins through degradation, today announced the hiring of Andrew Hirsch as the Company’s incoming chief executive
Sep 8, 2020

Toolkit